Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
148038-34-6
|
| gptkbp:hasMolecularFormula |
C17H16N8O2
|
| gptkbp:hasSMILES |
c1cc(c(cc1)CCN2C(=NNC3=NC(=NC(=N32)N)C4=COC=C4)N)O
|
| gptkbp:heldBy |
adenosine A2A receptor antagonist
|
| https://www.w3.org/2000/01/rdf-schema#label |
ZM 241385
|
| gptkbp:is_not_approved_for |
clinical use
|
| gptkbp:IUPACName |
4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol
|
| gptkbp:molecularWeight |
364.36 g/mol
|
| gptkbp:PubChem_CID |
5311106
|
| gptkbp:synonym |
4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol
|
| gptkbp:target |
adenosine receptor A2A
|
| gptkbp:used_in |
scientific research
|
| gptkbp:usedFor |
pharmacological tool
|
| gptkbp:bfsParent |
gptkb:CHEMBL1173605
|
| gptkbp:bfsLayer |
7
|